Clinical Trials on Health Insurance Sale in Australia

Total 3483 results

Hoffmann-La Roche

Completed

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Healthy Male Subjects

Australia, New Zealand
Celltrion

Completed

A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

Healthy Male Subjects

Australia
Amelia Gulliver
Australian Institute of Sport

Completed

The Elite Athlete Mental Health Strategy Trial (TEAMS)

Mental Health Help-Seeking

Australia
Pharmanex
Clinical Research Australia

Recruiting

Nutritional Supplement's Effects on Cognition

Healthy | Cognition | Dietary Supplement

Australia
Medical University of Vienna

Completed

Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle

Healthy Male Volunteers

Austria
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) (CUPID)

Metastatic Prostate Cancer

Australia
Alvotech Swiss AG

Completed

AVT03 With Prolia in Healthy Male Subjects

Healthy Male Subjects

South Africa, Australia, New Zealand
Telix International Pty Ltd

Completed

177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study (ProstACTSelect)

Metastatic Prostate Cancer

Australia
Repromed

Completed

Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility

Oxidative Stress | Infertility, Male

Australia
The Alfred

Completed

Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone

Heart Failure | Healthy

Australia
Medical University of Vienna

Completed

The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

Healthy Human Male Subjects

Austria
Peter MacCallum Cancer Centre, Australia
Varian Medical Systems

Recruiting

Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy (POPSTAR II)

Oligometastatic Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Endocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation...

Active, not recruiting

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (LuTectomy)

Prostatic Neoplasms

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (LuCAB)

Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
AdvanCell Isotopes Pty Limited

Recruiting

Dose Escalation and Efficacy Study of 212Pb-ADVC001 in Patients With Metastatic Castration Resistant Prostate Cancer.

Prostatic Neoplasms | Castration-Resistant

Australia
Murdoch Childrens Research Institute
National Health and Medical Research Council, Australia; Royal Children's Hospital and other collaborators

Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents (GenV)

Communicable Diseases | Quality of Life | Inflammation | Obesity | Congenital Abnormalities | Genetics | Healthy Aging | Child Development | Diet | Mental Health | Disability | Injuries | Cognition | Child Health | Environmental Exposure | Noncommunicable Diseases | Physical Fitness | Intergenerational Relations | Social Determinants... and other conditions

Australia
Edith Cowan University
Flinders University; The University of Western Australia

Completed

Nitrate INFORMER Vegetable Study

Health Risk Behaviors

Australia
Edith Cowan University
Flinders University; The University of Western Australia

Completed

Nitrate INFORMER Water Study

Health Risk Behaviors

Australia
Edith Cowan University
Flinders University; The University of Western Australia

Completed

Nitrate INFORMER Nitrosamine Study

Health Risk Behaviors

Australia
Cindy Hall

Withdrawn

Is Left Stellate Ganglionectomy Beneficial to Patients With Life Threatening Ventricular Arrhythmias (Reduce-SCD)

Sudden Cardiac Death

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

ProsTIC Registry of Men Treated With PSMA Theranostics

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T (VIOLET)

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia
St Vincent's Hospital, Sydney

Recruiting

PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI (PRIMARY2)

Prostate Cancer

Australia
Telix Pharmaceuticals (Innovations) Pty Limited

Active, not recruiting

External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)

Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancer (AlphaBet)

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
Australian and New Zealand Urogenital and Prostate...
Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...

Active, not recruiting

EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (ANZUP2001)

Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic Disease

Australia
St Vincent's Hospital, Sydney
Clarity Pharmaceuticals Ltd

Completed

Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP) (BOP)

Prostate Cancer

Australia
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics of PN-232 in Healthy Volunteers

Healthy Subjects

Australia
Peter MacCallum Cancer Centre, Australia
United States Department of Defense; Advanced Accelerator Applications; Australian... and other collaborators

Active, not recruiting

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy (UpFrontPSMA)

Metastatic Hormone Naive Prostate Cancer

Australia
Atossa Therapeutics, Inc.

Completed

AT-301 Nasal Spray in Healthy Adults

Healthy

Australia
Kowa Company, Ltd.

Completed

A Study to Evaluate the Safety of K-755 in Healthy Volunteers

Healthy

Australia
Concert Pharmaceuticals

Completed

Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656

Healthy

Australia
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study in Healthy Volunteers

Healthy

Australia
Cumberland Pharmaceuticals

Completed

Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects

Healthy

Australia
Avanir Pharmaceuticals

Completed

Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers

Healthy

Australia
University of Adelaide

Completed

Assessment of an Electronic Voting System Within the Tutorial Setting. A Randomised Controlled Trial

Healthy

Australia
AstraZeneca

Completed

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

Heart Failure, Congestive

Australia
Melbourne Health
Austin Health; Peter MacCallum Cancer Centre, Australia; St Vincent's Hospital; Epworth Healthcare

Not yet recruiting

National Robotics-Assisted Radical Prostatectomy Database (RoPCa-ND)

Prostate Cancer | Learning Curve | Patient Reported Outcome Measures | Oncological Outcomes | Database | Robotic-assisted Radical Prostatectomy | Surgical Outcomes

Australia
MycoMedica Life Sciences PBC

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants

Healthy Volunteers

Australia
Tavotek Biotherapeutics

Active, not recruiting

Study of TAVO101 in Healthy Volunteers

Healthy Subjects

Australia
AN2 Therapeutics, Inc

Completed

Phase 1 Study of Epetraborole Tablets

Healthy Volunteers

Australia
ImmuneMed, Inc.

Completed

Safety, Tolerability, Pharmacokinetics of hzVSf-v13 in Healthy Adults (Intravenous and Subcutaneous Administration)

Healthy Volunteers

Australia
SIMR (Australia) Biotech Pty Ltd.

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375

Healthy Volunteers

Australia
Inmagene LLC

Completed

Evaluate IMG-007 in Healthy Participants

Healthy Participants

Australia
Atridia Pty Ltd.

Completed

A Trial of SHR2285 in Healthy Subjects

Healthy Volunteers

Australia
BeiGene

Completed

Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy Subjects

Healthy Volunteers

Australia
GlaxoSmithKline

Completed

GW823296 Repeat Dose Study In Healthy Male And Female Subjects

Healthy Subjects

Australia
Puzzle Medical Devices Inc.

Not yet recruiting

Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance

Heart Failure | Acute Decompensated Heart Failure | Heart Failure With Reduced Ejection Fraction | Heart Failure, Congestive | Heart Failure With Preserved Ejection Fraction | Cardiorenal Syndrome | Diuretic Resistance

Australia
St Vincent's Hospital, Sydney

Completed

Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer (HITMAN-PC)

Prostate Cancer

Australia
University of Adelaide

Recruiting

Effects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic Control

Healthy

Australia

Clinical Trials on Health Insurance Sale in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations